SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-23-000969
Filing Date
2023-01-05
Accepted
2023-01-05 16:06:12
Documents
2
Period of Report
2022-12-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1560
2 EX-24 DOCUMENT attachment1.htm EX-24 3890
  Complete submission text file 0000899243-23-000969.txt   6886
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Issuer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 17520 HIGH BLUFF DRIVE SUITE 250 SAN DIEGO CA 92130
Business Address
Eastling Thomas Wilson (Reporting) CIK: 0001958487 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51173 | Film No.: 23511300